GenScript Biotech Global Forum London 2024

About this event

(1) GenScript Biotech Global Forum London 2024

Gene and cell therapy is booming worldwide, fueled by major innovations in life science and medicine and funding from global capital markets. To advance this crucial field, GenScript convenes top scientists and industry leaders from around the world, concurrent with Jefferies London Healthcare Conference. The upcoming GenScript Biotech Global Forum London 2024 will take place in London on Wednesday, November 20, 2024.

Under the theme of Unlock the Full Potential of Cell and Gene Therapies, GenScript is inviting gene and cell therapy thought leaders from the research, industry, and capital communities as well as representatives from regulatory bodies to focus on recent developments in research, technological breakthroughs, and regulatory trends. We are looking forward to hosting thought leaders from around the world, united in the pursuit of cures to help more patients.

(2) Confirmed Speakers

• Dima AI-hadithi, CEO, Minaret Consulting Limited
• Karim Benabdellah, GENYO, Pfizer/University of Granada/Andalusian Regional Government
• Qingyu Cao, Senior Director, Head of European Business Development ,ProBio
• Ming Ewe, CEO, Smarter Biotech Solutions
• Jim Faulkner, CEO, JDB BioConsulting
• Miguel Forte, M.D., Ph.D., President of International Society for Cell & Gene Therapy (ISCT); ARM Board Member, Chief Executive Officer of Kiji Therapeutics
• Jason Foster, CEO, Ori Biotech
• Stephen Hansen, Director of Biopharma Intelligence, BioCentury
• Ying Huang, CEO, Legend Biotech
• Reagan Jarvis, CEO and Co-founder, Anocca AB
• Peter Jones, Director, Pengwin Consultancy
• Arindam Mitra, CMC Director, Leucid Bio
• Deividas Pazeraitis, Senior Scientist, AstraZeneca
• Maelle Quere, Scientists, Sanofi
• Sherry Shao, Rotating CEO, GenScript
• Ping Shek, Managing Director, Stifel’s Global Healthcare Group
• Pascal Touchon, Chairman of the Board, Atara Biotherapeutics
• Tom Whitehead, Co-Founder Emily Whitehead Foundation
• James M. Wilson, M.D, Ph.D, President and CEO, Gemma Biotherapeutics (GEMMABio); Founder and Advisor – Scout Bio, Passage Bio, iECURE; Executive Chair, Franklin Biolabs
• Lumeng Ye, Director of Novel therapeutic materials, R&D Dept, GenScript Biotech
• Biao Zheng, CEO, BRL Medicine Inc

The above is sorted by the first letter of the guest surnames*

(3) Hot Topics

• TECHNOLOGY INNOVATION AND BREAKTHROUGHS IN CELL THERAPY
• PROGRESS IN GENE THERAPY AND mRNA VACCINE
• CMC CHALLENGES WITH DEVELOPING & MANUFACTURING CELL AND GENE THERAPIES
• NAVIGATING THE FUTURE OF CGT: INSIGHTS FROM INVESTORS
• STATUS AND EXPECTATIONS FOR CELL AND GENE THERAPY IN 2024 AND BEYOND

(4) Schedule: (GMT Time Zone)

• Registration: 12:00 P.M.-1:30 P.M.
• Program: 1:30 P.M.- 6:25 P.M.
• Reception: From 6:25 P.M.

We would like to extend to you a cordial invitation to join your peers at what promises to be a unique opportunity to share insights and collaborate on the global advancement of cell and gene therapy in London in November 2024.

*Program schedule and speakers are subject to change.

For more information , please visit the forum website at:

We are looking forward to seeing you in London in November!